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Legal Liability Under Managed Care 
Kenneth S. Robbins Esq. 
Market forces are driving the delivery of health care into man-
aged care. New alignments among health care providers, pay-
ers, utilization reviewers and hospitals create new /ega/liability. 
Better-informed patients, concurrent credentialing by hospitals 
and payers, and new incentives to reduce hospital and 
physician-related costs have resulted in new federal legislation 
and agencies that reshape health care delivery and /ega/liabil-
ity. 
Introduction 
Managed care is coming to Hawaii. Indeed, it is in place to a 
great extent in many areas of this country. The politicos in 
Washington may differ noisily as to how delivery of health care 
should be retooled, but the inexorable forces of the marketplace 
are moving the delivery of health care into managed care. Some 
insurers and physician groups are purchasing hospitals. Some 
hospitals are dispensing with independent medical staffs and are 
employing physicians directly. Like it or not, we must anticipate 
what managed care will bring. Part of what managed care will 
bring are new alignments among insurers, hospitals, and physi-
cians, and with those realignments both major and subtle changes 
in legal liability within a managed care system will be seen. 
A review of the forces driving us toward managed care yields 
insight into what those legal liability changes probably will be. 
Using a medical analogy, if we evaluate what the disease within 
the system is, we can anticipate the attempted cure and the side 
effects of the cure. 
Economic Forces Driving Toward Managed 
Care 
In 1994 the United States acknowledged its participation in a 
global economy. NAFfA and GATT thrust us anew into the 
global marketplace. Current discussions and negotiations with 
Pacific Rim countries will undoubtedly yield even more formal 
agreements between the United States and its Pacific Rim 
trading partners. Increased participation in the global economy 
means, among other things, that anything spent on goods and 
services that cannot be exported and sold abroad will make us 
less competitive in the international marketplace. Unquestion-
ably, exploitation of medical technology and know-how is, and 
should be, a significant component of our trade overseas, but 
expenditures for health care within our country are a resource 
not favorably affecting the balance of trade. Unnecessary expen-
ditures within a wasteful health care delivery system renders us 
less competitive in the global marketplace. 
Health Care Finance and Review demonstrates vividly the 
increasing percentage of gross national product consumed by 
U.S. national health expenditures (Fig 1). Under the current 
system, a full32% of gross national product will be consumed 
by health expenditures by 2030. A jump from 5.3% of GNP in 
1960 to 32% in 2030 would destroy any attempt for this country 
-
to compete internationally. 
In 1990, health care expenditures in the United States were 
almost twice that of our primary Pacific economic competitor, 
Japan, and almost four times that of China (Fig 2, 3). The 
remarkable statistic of 1.9% for Singapore is probably the result, 
in large part, of a system called Medisave. In Singapore, what-
ever portion of an annual health care expenditure allotment an 
individual does not spend is deposited into a pension plan for that 
individual. This system of incentives to save money can be 
argued to support a system under managed care into which 
incentives can be built. Such incentives will undoubtedly yield 
interesting twists in the area of health care practitioner legal 
liability. 
A given then is the percentage of gross national product spent 
in this country on health care as one of the significant factors that 
reduces our global economic competitiveness. 
The disease is a costly health care system. A look at the most 
expensive components of the system points out what the at-
tempted cure will include (Fig 4 ). Of particular interest is the fact 
that hospital care constitutes 38 cents of each health care dollar 
spent in 1990. Physician services are the next largest single 
cause of health care expenditures. Therefore, it is not unreason-
able to project that a managed care system will ultimately be in 
place that will 1) be incentivized to reduce total health care 
expenditures; 2) target, in particular, the cost of hospital care; 
and 3) will be designed to reduce the cost of physician services. 
Fig 1.-U.S. National Health Expenditures 1980 to 2030 
GROSS NATIONAL 
DOMESTIC HEALTH 
PRODUCT EXPENDITURES PERCENT OF 
YEAR (Billions) (Billions) GOP 
1980 $2,708 $250.1 9.2 
1990 $5,514 $666.2 12.1 
1991 $5,674 $736.5 13.0 
1992 $5,909 $819.9 13.9 
1993 $6,259 $903.3 14.4 
1995 $7,069 $1,101.9 15.6 
2000 $9,637 $1.739.8 18.1 
2010 $17,238 $3,787.8 22.0 
2020 $29,594 $7,839.4 26.5 
2030 $49,936 $15,969.6 32.0 
NOTE: 1992-2030 Projected. 
SOURCE: Health Care Financing Review, Fall 1992, 
Vol. 14, No.1. 
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Fig 2.-National Health Expenditures as a Percent of GOP, Selected 
OECO Countries, 1970 to 1990 
Country 
1970 
PERCENT OF GOP 
1975 1980 1985 1989 1990 
Canada 7.1 7.2 7.4 8.5 8.8 9.3 
France 5.8 7.0 7.6 8.5 8.7 8.8 
Germany 5.9 8.2 8.4 8.7 8.2 8.1 
Italy 5.2 6.1 6.9 7.0 7.6 7.7 
Japan 4.4 5.5 6.4 6.5 6.6 6.5 
United 4.5 5.5 5.8 6.0 6.1 6.2 
Kingdom 
United 7.4 8.4 9.2 10.5 11.5 12.1 
States 
SOURCE: Schieber and Poullier (1991); Scheiber, 
Poullier, and Greenwald (1992). 
What is Managed Care? 
Managed care within the context of the delivery of health care 
services is a carefully planned system within which the follow-
ing are important components: 
1. An agreement by a hospital or related organization to 
provide certain health care services; 
2. Those certain health care services are subject to a system 
designed to assure proper utilization and quality of care; 
3. In exchange for a payment by a third-party payer. 
This management of care may be imposed solely by the payer, 
by hospitals, or medical service organizations in concert with 
payers, physicians, and hospitals. There are almost countless 
potential configurations of interrelationships among compo-
nents of managed care systems. There is no indication which 
configuration of the many possibilities will be implemented 
eventually in Hawaii. Currently physicians, medical center and 
clinic CEOs, and attorneys are attending many seminars and 
programs being offered with a view toward deciding on and 
implementing managed care systems in Hawaii. 
With the foregoing components of managed care in mind and 
reflecting on the economic forces driving us toward managed 
care, it can be predicted with probability that managed care in 
Hawaii will utilize a variety of devices to eliminate or minimize 
to every extent possible the economic uncertainties of the 
present health care delivery system. Under the present system, 
a third-party payer, such as HMSA, will reimburse a fixed 
percentage of approved services. Although reimbursement is for 
approved services only and at a fixed percentage, there is 
enormous financial uncertainty within the current system. The 
current system is tantamount to a system of property insurance 
in which an insurer agrees to reimburse a homeowner 80% of 
whatever the replacement cost may be of a home destroyed by 
fire. To be sure, a replacement home under those circumstances 
will be considerably grander and more expensive than if the 
home were replaced under a system in which the insurer im-
posed a fixed limitation on the cost of a replacement home. 
A concept of capitation will incorporate into managed care the 
fixed limitation on the amount available for health care for each 
Fig 3.-National Health Expenditures as Percentage of GOP 1990, 
Selected Asian Countries 
COUNTRY % ofGDP 
India 6.0 
China 3.5 
Indonesia 3.7 
Japan 6.5 
Pakistan 3.4 
Philippines 2.0 
Thailand 5.0 
South Korea 6.6 
Sri Lanka 3.7 
Hong Kong 5.7 
Singapore 1.9 
Malaysia 3.0 
Papua New Guinea 4.4 
SOURCE: World Bank. 
patient/participant in the program. As an example, if the system 
allocates for each patient/member of a particular managed care 
program a total of $5,000 a year for total health care costs, 
including hospitalization, physician charges, drugs, etc, the 
managed care system will make money if less than $5,000 per 
patient is spent. Money will be lost if more than $5,000 is spent 
per year per member for health care expenditures. A similar 
system is already in place in Hawaii and throughout the Main-
land in the form of health maintenance organizations (HMOs). 
Major and Subtle Changes of Legal Liability 
of Managed Care 
A look at the economic forces driving us toward managed care, 
and the realignment of hospitals, physicians, and insurers within 
a system of capitation, suggest what the legal liability issues will 
be in a managed care system. 
Independent medical staff will lose its meaning in a system in 
which physicians own a hospital or in which a hospital employs 
physicians. Hospital administration will not have available to it 
the defense that it exercises no control over a physician's 
independent practice of medicine within its physical facilities. 
The hospital will have total vicarious liability for the acts and 
omissions of the physicians whom it employs. Therefore, a 
hospital-employed physician will no longer have the incentive 
to point the finger of liability at hospital employees and, con-
versely, the hospital will not have the incentive to point the 
finger ofliability at the physician, who is no longer a member of 
an independent medical staff. Indeed, the same attorney may 
represent both the hospital and the physician when both are sued 
by a patient. Under the present system, a patient may sue a 
hospital and also name as a defendant nurses employed by the 
hospital. Just as there is usually no conflict of interest for one 
attorney to represent both the hospital and the nurses in that 
-
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Fig 4.-The Nation's Health Dollar: 1990 
II PAYMENTSOURCE 
~ (Cents) 
[f Private Health Insurance 
Medicare 
.~Medicaid 
" Other Government 
il Other Private 
Direct Patient Payments 
EXPENDITURE 
(Cents) 
// Hospital Care 
.. Physician Services 
Nursing Home 
lr Other Personal Health Care 
Other Spending 
33 
17 
11 
14 
5 
20 
38 
19 
8 
23 
12 
NOTES: Other private includes industrial, non-patient revenue, private construction. Other 
personal care includes dental, drug, other goods and services. Other spending includes, administrative, 
research and construction. 
SOURCE: Health Care Financing Administration 
setting, there would be no conflict of interest for the same 
attorney to represent a hospital and a physician who is employed 
by that hospital. Therefore, terms such as "independent contrac-
tor," "ostensible agency" and "independent medical staff' may 
no longer be relevant in the medical malpractice setting. 
The reversal of incentive to treat a patient creates other legal 
liability issues. There will be incentives for hospitals to maintain 
the lowest possible census to reduce hospital expenditures 
within a system of capitation. Similarly, there will be incentives 
for physicians to see patients as infrequently as the standard of 
care will allow. Consequently, Medicare fraud and abuse con-
cerns may focus on a provider's failure to deliver sufficient 
services rather than a delivery of unnecessary services in ex-
change for payment. 
Managed care contracting among groups of physicians, hos-
pitals, and insurers can and will raise antitrust issues as providers 
and payers enter into exclusive arrangements. Therefore, it is 
imperative that exclusive arrangements among health care pro-
viders, hospitals, and insurers be drafted carefully to avoid 
antitrust issues. 
Various payment mechanisms can raise issues of fee-splitting 
which, again, should be addressed carefully in the formulation 
of managed care agreements. 
The provision of certain health care services, subject to a 
system designed to assure proper utilization and quality of care, 
can and probably will raise legal issues with respect to a payer's 
utilization review decision, which may limit access to care. 
Cases on the Mainland have already been the subject of consid-
erable publicity in which bone marrow transplants, for example, 
have been denied reimbursement by third-party payers. Accord-
ingly, patients will sue payers and providers independently and 
in parallel claims for provider's alleged negligent care and 
payer's imposing unreasonable limitations on the delivery of 
care because of this utilization review decision. This will create 
-
even greater polarity between payers and providers resulting in 
finger-pointing between payers and providers if a patient alleges 
failure to provide sufficient services. 
Concurrent credentialing by hospitals and payers or their 
affiliated utilization review organization will cause a retooling 
of peer review confidentiality and protection. Traditionally, 
hospitals are concerned with the competence of a physician. 
Under the present system a hospital's credentials committee will 
rarely concern itself with a physician's utilization track record. 
Again, what with an attempt to reduce hospital census and 
reduce the frequency of physician visits under a capitation 
system, credentialing will be based on both the physician's 
competence and utilization track record. A hospital may con-
clude that a physician is competent, while the payer component 
of the managed care system may wish to exclude the entry of a 
physician into the system because of a track record of over-
utilization . 
The credentialing process will, therefore, incorporate into it a 
much greater emphasis on a physician's morbidity and mortality 
track record. Not only will morbidity and mortality statistics 
become an integral part of credentialing decisions, but such 
statistics will become available to patients in formulating an 
informed decision in selecting physicians. 
Because hospitals and payers will each conduct their own 
credentialing process, peer review protection will either have to 
be broadened to include credentialing by payers or may be 
reduced or eliminated altogether as morbidity and mortality 
statistics are considered important information to be made 
available to patients in making health care decisions. 
Agency for Health Care Policy and Research 
Section 6103 of OBRA 1989 
The major functions of the Agency for Health Care Policy and 
Research section 6103 of OBRA 1989 creates a new Title IX of 
the Public Health Service Act: 1 
1. To conduct and support research, demonstration 
projects, evaluations, training, guideline development and 
the dissemination of information on health care services and 
systems for the delivery of such services including activities 
with respect to: a) the effectiveness, efficiency and quality 
of health care services and procedures; b) the outcomes of 
health care services and procedures; c) clinical practice, 
including primary care and practice-oriented research; d) 
health care technologies, facilities, and equipment; e) health 
care costs, productivity and market forces; f) health promo-
tion and disease prevention; g) health statistics and epidemi-
ology; and h) medical liability. This legislation also will 
assess health technology and establish an advisory council 
for health care policy, research, and evaluation. 
What will probably be the most controversial and discussed 
component of this new legislation is the establishment of the 
Office of the Forum for Health Quality and Effectiveness. This 
office will arrange for the development, periodic review and 
updating of clinically relevant guidelines that may be used by 
physicians, educators and health care practitioners to assist in 
determining how diseases, disorders and other health conditions 
most effectively and appropriately can be prevented, diagnosed, 
treated and managed clinically. 
Further, the Office of the Forum for Quality and Effectiveness 
will develop, review periodically, and update standards of 
quality, performance measures and medical review criteria 
through which health care providers and other appropriate 
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entities may assess and review the provision of health care and 
assure the quality of such care. Such guidelines, standards, 
performance measures and review criteria are to be based on the 
"best available research and professional judgment" and are to 
be presented in formats appropriate for use by physicians, health 
care practitioners, providers, medical educators, and medical 
review organizations, and in formats appropriate for use by 
consumers of health care. This will include treatment-specific 
or condition-specific practice guidelines for clinical treatments 
and conditions, and forms appropriate for use in clinical prac-
tice, educational programs, and in reviewing quality and appro-
priateness of the medical care. 
Priorities in establishing such practice guidelines, standards, 
performance measures and review criteria will be prioritized 
based on needs of Medicare, particularly high-cost or controver-
sial items and items with substantial variation nationally. Among 
those areas of clinical practice selected for application of the 
guidelines, standards, performance measures, and review crite-
ria are: 
• Post-operative pain management 
• Urinary incontinence in adults 
• Prediction and prevention of bedsores 
• Benign prostatic hypoplasia 
• Low-back pain problems 
• Depression treated by primary care physicians in an 
out-patient setting 
• Evaluation and management of early HIV infection 
• Management of cancer-related pain 
• Treatment of pressure ulcers in adults 
• Quality determinants of mammography 
• Otitis media with effusion in children 
• Heart failure: evaluation and care of patients with left 
ventricular systolic dysfunction 
• Post-stroke rehabilitation 
• Screening for Alzheimer's disease and related dementia 
• Cardiac rehabilitation 
• Diagnosis and management of unstable angina 
• Smoking prevention and cessation 
• Diagnosis and treatment of anxiety and panic disorder in 
a primary care setting 
Definitions within this new legislation are as follows: 
• Practice guidelines: Systematically developed statements 
to assist practitioner and patient decisions about appropri-
ate health care for specific clinical circumstances. 
• Medical review criteria: Systematically developed state-
ments that can be used to assess the appropriateness of 
specific health care decisions, services and outcomes. 
• Standards of quality: Authoritative statements of 1) 
minimum levels of acceptable performance or results, 2) 
excellent levels of performance or results, or 3) the range of 
acceptance performance or results. 
• Performance measures: Methods or instruments to esti-
mate or monitor the extent to which the actions of a health 
care practitioner or provider conform to practice guidelines, 
medical review criteria, or standards of quality. 
"Cookbook" Medicine from a Legal Liability 
Viewpoint 
There are seemingly insurmountable obstacles in developing 
practice guidelines in some areas, such as treating back pain. 
Once the obstacles are overcome and practice guidelines are 
developed and put in place, the question arises as to whether 
-
deviation from the guidelines can be used by a patient in a 
lawsuit against a physician. Physicians argue that the establish-
ment of practice guidelines that cannot possibly apply in every 
instance to every patient will now provide patients and their 
attorneys with even more ammunition in medical malpractice 
lawsuits. 
Once practice guidelines are enacted, won't this give patients 
and their attorneys new ammunition to use in lawsuits against 
physicians? Maine and other states have confronted this poten-
tial problem by decreeing by statute that only the defendant 
physician may refer to practice guidelines in his or her defense. 
In other words, practice guidelines cannot be raised initially by 
the patient's attorney to prove a deviation from the guideline 
and, thus, care and treatment below the standard of care. Ini-
tially, only the physician's attorney can utilize as evidence a 
practice guideline to show conformance with the guideline as a 
defense for a medical malpractice lawsuit. Therefore, in Maine 
and the other states, a practice guideline in a medical malpractice 
lawsuit is not a spear, it is a shield. 
Whatever the legal liability implications may be of practice 
guidelines or practice parameters, the demonstration project in 
Maine appears to have some profound impact on the practice of 
medicine. A Wall Street J ournaP article said that 80% of prac-
ticing physicians in Maine are participating in the demonstration 
project, it is reported that prior to the imposition of practice 
parameters, 95% of all victims of falls and car accidents were 
ordered to have $170 neck x-rays at the emergency room of 
Maine Medical Center. Following the imposition of the practice 
parameters, that percentage was reduced to 50%. It is also 
reported that anesthesiologists are now doing fewer blood tests 
Fig 5.-sample Protocol in Maine Medical Liability Demonstration 
Project Excerpts 
MEDICAL UABILITY DEMONSTRATION PROJECT 
OBSTETRICS AND GYNECOLOGY PRACTICE PARAMETERS 
CONTENTS: 
I. Procedure: 
II. Procedure: 
m. Procedure: 
N. Procedure: 
V. Procedure: 
VI. Condition: 
VII. Condition: 
VTII. Condition: 
IX. Condition: 
X. Topic: 
Cesarean Delivery for Failure to Progress 
Assessment of Fetal Maturity prior to repeat Cesarean delivery or 
elective induction of labor 
Hysterectomy, abdominal (68.4) or vaginal (68.5) 
Hysterectomy, abdominal (68.4) or vaginal (68.5) 
Tocolysis 
Presumed Ectopic Pregnancy in a clinically stable patient 
Singleton Breech Presentation 
Perinatal Herpes Simplex Virus Infections 
Intrapartum Fetal Distress 
Antepartum Management of Prolonged Pregnancy 
IV. PROCEDURE: HYSTERECTOMY, ABDOMINAL (68.4) OR VAGINAL (68.5) 
A. Indication: Abnormal uterine bleeding in women of reproductive age (626 all, except 
626.0, 626.1, 626.3, 626.7)* 
Confirmation of indication: 
1. History of all of the following: 
a. Excessive uterine bleeding or irregular uterine bleeding defined as bleeding for 
more than 8 days during more than a single cycle and profuse bleeding 
requiring additional protection;** 
b. No history of a bleeding diathesis or use of medication that may cause 
bleeding; 
c. Negative effect on patient's quality of life. 
2. Failure to find on physical examination, uterine or cervical pathology that would 
cause abnormal bleeding. 
3.Laboratory data: 
a. No finding of endometrial neoplasia; 
b. No malignancy found in cytological studies of cervix. 
4. No finding of endometrial polyps by D&C, hysteroscopy, or hysterogram. 
B. Actions Prior to Procedure: 
1. Determine that attempted hormone treatment (estrogen-progestogen) was not 
successful or contraindicated or refused. 
2. Hemoglobin or hematocrit documented. 
3. Document and attempt to correct anemia if present. 
4. Offer autologous blood donation if appropriate. 
5. Document patient education and informed consent. 
C. Contraindication: 
1. Desire to maintain fertility. 
Reference: Quality Assurance in Obstetrics & Gynecology, 1989 ed. 
• Other diagnoses that should also be evaluated according to these criteria include menorrhagia (626.2, 
627.01, hypermenorrbea (626.2). 
** For example, large clots, gushes, irritations on activity. 
[Me Rev Stat Ann X 24, Section 2971 (West Supp 1991)) 
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and chest x-rays before surgery. Radiologists are saying that the 
guidelines are one reason why they no longer require as many 
patients to stay overnight in the hospital after certain blood 
vessel x-rays. 
One thing is certain: When practice parameters/guidelines are 
in place and a consumer version of the practice parameters is 
published for use by patients, the often-heard allegation of"lack 
of informed consent" will be heard less and less. Some health 
care practitioners may view the prospect of a dialog between 
practitioner and patient, each with his or her version of the 
relevant practice guideline in hand, as yet another burden for the 
health care profession to carry. Patients who are armed with their 
own practice guidelines when they come to the physician's 
office will certainly have more questions and will initiate more 
discussion regarding the proposed treatment. This may consume 
more time and affect the bottom line because fewer patients will 
be seen. However, when a physician charts reference to the 
practice guideline and the fact that the patient was referred to the 
consumer version of the practice guideline, and there was full 
discussion about the practice guideline, it will be extremely 
difficult for that patient to claim later that he or she lacked 
informed consent before the care/treatment/procedure began. 
Therefore, the patient who is armed with knowledge may be 
viewed as an irritant, but ultimately, that patient will have less 
to complain about if a recognized risk of the procedure is 
encountered post-operatively. 
When practice parameters are discussed in the Hawaii Legis-
lature, it is proposed that the treatment/procedure guidelines be 
included along with alternatives, the risks, so there can be no 
question about a patient's having participated in a discussion 
about these issues and the material covered in guidelines, such 
as those proposed in Maine. If practice parameters include a 
thorough discussion of the recognized alternatives and risks of 
a procedure, a physician who follows the guidelines and who 
furnishes to a patient the consumer version of the practice 
guidelines should never lose a case on the issue of lack of 
informed consent. This is particularly important because a 
recent Hawaii Appellate case says, in effect, that a patient who 
signs an informed consent form on which all of the pertinent 
information appears with respect to providing informed consent 
is not conclusive evidence that informed consent was obtained 
from the patient before a procedure. 3 
Legal Liability Fallout Under Managed Care 
Maintenance of morbidity and mortality statistics with respect 
to practitioners such as surgeons will mean more stringent 
controls on the delivery of health care and, therefore, clearer 
guidelines for evaluating which physicians should and should 
not be licensed, have staff privileges, and how their care can be 
evaluated. Therefore, there will be a new balance struck between 
a physician's right to a license, to staff privileges, and 
cost-effective reasons for precluding or removing a license and 
staff privileges. We will see more administrative altercations 
between licensing authorities and physicians, and credentialing 
bodies in hospitals and physicians. 
We will see more lawsuits against hospitals for negligent 
credentialing. Because there will be greater emphasis on afford-
ing privileges within much more stringent control parameters, 
patients' attorneys will look increasingly to the information 
available or what should have been available to an institution 
before a practitioner was granted staff privileges. 
Market forces will move us toward capitation and reduction of 
hospital and physician-related costs. Therefore, we will see an 
expanded role of nurses and the creation of new areas of nursing 
liability. As an example, if patients are discharged earlier from 
hospitals to reduce post-operative hospital care costs, it will 
probably be nurses and not physicians who will go to the home 
of a patient for post-operative evaluation. This will require a 
higher level of decision-making among nurses and will require 
a heightened level of communication between nurses and phy-
sicians. 
Of all the things that feel uncomfortable and are disliked most 
is change. In discussions with groups of physicians regarding 
what managed care will mean in terms of the law and liability, 
it is extremely obvious that physicians are anxious, fearful and 
angry about the prospect of the changes managed care will bring. 
Whether it's lawyers who represent patients and cases against 
physicians, lawyers who handle the corporate and business 
aspects of a changeover into managed care, or lawyers who 
represent physicians in a medical malpractice lawsuit, physi-
cians are now of the mind that all lawyers are the enemy and 
managed care is what lawyers are creating. This is not true. 
Economic forces are driving the health care delivery system into 
managed care. Although non-lawyers do not like to view law-
yers as victims, the economic forces behind managed care are in 
fact victimizing attorneys as much as physicians. The economic 
forces are bigger than the medical and legal professions. Whether 
we are physicians or attorneys, managed care is coming and both 
professions are well advised to adapt as much as they can, rather 
than fighting the process along the way. 
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~IJNtd~ 
"Since you cured my split 
personality, I suffer terribly 
from loneliness." 
-
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